combined oral contraceptives
Oral contraception: a pharmacist’s guide
A guide to what pharmacists need to know about the composition, use, safety profile and efficacy of oral contraceptives. By Professor Rod Baber AM, BPharm, MBBS, FRCOG, FRANZCOG Learning Objectives …
Alternative OCP approved to address shortages
TGA grants approval for import and supply of two alternative products to address the Brevinor and Norimin shortages The TGA advised health professionals and consumers in August that there was …
Shortage alert
Pharmacists are advised that there is a shortage of oral contraceptive pills containing the combination ethinylestradiol and norethisterone The TGA has advised health professionals and consumers that there is a …
Could newer hormonal contraceptives reduce ovarian cancer risk?
A nationwide cohort study has found contemporary forms of hormonal contraception prevented an estimated 21% of ovarian cancers in young women About 100 million women around the world use hormonal …
Combined OCPs protective for lifetime cancer risk
An extensive study has found oral contraceptive use is associated with reduction in some cancers for up to 35 years The study of more than 46,000 women recruited by the …
Combined pill increases blood clot risk: review
Be aware but not “unduly alarmed” by increased risk of blood clots linked to combined hormonal contraceptives, says TGA For women using one of the combined hormonal contraceptives currently available …